Search

Search Constraints

You searched for: Author/Creator Rai, Shinya

Search Results

1. A multicenter, open‐label, phase II study of tirabrutinib (ONO/GS‐4059) in patients with Waldenström's macroglobulinemia. Issue 9 (20th July 2020)

2. A phase 2 study of polatuzumab vedotin + bendamustine + rituximab in relapsed/refractory diffuse large B‐cell lymphoma. Issue 7 (4th June 2021)

4. Decreased expression of T‐cell‐associated immune markers predicts poor prognosis in patients with follicular lymphoma. Issue 2 (5th December 2021)

6. Mice doubly‐deficient in the Arf GAPs SMAP1 and SMAP2 exhibit embryonic lethality. Issue 19 (18th August 2015)

7. Multiple cytokine-producing B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and classic Hodgkin lymphoma with autoimmune hemolytic anemia. Issue 2 (28th January 2021)

8. Novel prognostic predictor of haemoglobin–platelet index in diffuse large B‐cell lymphoma, not otherwise specified: Anaemia and thrombocytopenia are associated with IL‐6 production in lymphoma cells. (22nd April 2022)

9. Phase II study of tazemetostat for relapsed or refractory B‐cell non‐Hodgkin lymphoma with EZH2 mutation in Japan. Issue 9 (14th July 2021)